Dow Jones

44,638.83

-0.52%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

HCWB

HCW Biologics (HCWB)

HCW Biologics Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HCWB

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
03/02/2025	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HCWB	HCW Biologics Inc
03/02/2025	06:15	GlobeNewswire Inc.	HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial	NASDAQ:HCWB	HCW Biologics Inc
15/01/2025	06:00	GlobeNewswire Inc.	HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025	NASDAQ:HCWB	HCW Biologics Inc
23/12/2024	07:10	GlobeNewswire Inc.	HCW Biologics Inc. Received NASDAQ Staff Determination Letter	NASDAQ:HCWB	HCW Biologics Inc
05/12/2024	15:37	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:HCWB	HCW Biologics Inc
22/11/2024	15:53	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:HCWB	HCW Biologics Inc
20/11/2024	11:54	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NASDAQ:HCWB	HCW Biologics Inc
18/11/2024	20:27	GlobeNewswire Inc.	HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules	NASDAQ:HCWB	HCW Biologics Inc
18/11/2024	06:00	GlobeNewswire Inc.	HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate	NASDAQ:HCWB	HCW Biologics Inc
14/11/2024	16:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HCWB	HCW Biologics Inc
14/11/2024	15:40	GlobeNewswire Inc.	HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
23/08/2024	15:35	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:HCWB	HCW Biologics Inc
23/08/2024	15:30	GlobeNewswire Inc.	HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction	NASDAQ:HCWB	HCW Biologics Inc
14/08/2024	15:35	GlobeNewswire Inc.	HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
17/06/2024	15:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
20/05/2024	15:36	Edgar (US Regulatory)	Form ARS/A - Annual Report to Security Holders: [Amend]	NASDAQ:HCWB	HCW Biologics Inc
15/05/2024	15:39	GlobeNewswire Inc.	HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
15/05/2024	15:35	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:HCWB	HCW Biologics Inc
01/04/2024	15:10	GlobeNewswire Inc.	HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
14/11/2023	06:00	GlobeNewswire Inc.	HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
08/11/2023	06:30	GlobeNewswire Inc.	Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting	NASDAQ:HCWB	HCW Biologics Inc
01/11/2023	06:30	GlobeNewswire Inc.	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting	NASDAQ:HCWB	HCW Biologics Inc
06/09/2023	06:30	GlobeNewswire Inc.	HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023	NASDAQ:HCWB	HCW Biologics Inc
11/08/2023	06:00	GlobeNewswire Inc.	HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
10/08/2023	16:01	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:HCWB	HCW Biologics Inc
15/06/2023	16:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HCWB	HCW Biologics Inc
14/06/2023	16:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HCWB	HCW Biologics Inc
14/06/2023	06:30	GlobeNewswire Inc.	HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders	NASDAQ:HCWB	HCW Biologics Inc
09/05/2023	06:15	GlobeNewswire Inc.	HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
27/04/2023	15:26	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:HCWB	HCW Biologics Inc